HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis.


In humans, a low HDL concentration is one of the strongest indicators of increased risk for coronary heart disease. Apolipoprotein A-I (apo A-I) synthetic defects results in extremely low HDL levels and are frequently although not invariably associated with premature atherosclerosis. To investigate atherosclerosis susceptibility associated with HDL… (More)


  • Presentations referencing similar topics